Nova Leap Health (TSXV:NLH) - Aandelenkoers, Nieuws & Analyse

NLH Overzicht aandelen

Nova Leap Health Corp. levert samen met haar dochterondernemingen diensten op het gebied van thuis- en thuiszorg in de Verenigde Staten en Canada.

Over het bedrijf

NLH fundamentele analyse
Sneeuwvlok Score
Waardering	3/6
Toekomstige groei	0/6
Prestaties in het verleden	2/6
Financiële gezondheid	6/6
Dividenden	0/6

Beloningen

Trading at 53.8% below our estimate of its fair value

Became profitable this year

Risicoanalyse

Large one-off items impacting financial results

Does not have a meaningful market cap (CA$27M)

Nova Leap Health Corp. Concurrenten

NeuPath Health

TSXV:NPTH

CA$9.0m

ARCpoint

TSXV:ARC

CA$8.8m

Premier Health of America

TSXV:PHA

CA$8.0m

Leveljump Healthcare

TSXV:JUMP

CA$4.8m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Nova Leap Health
Historische aandelenkoersen
Huidige aandelenkoers	CA$0.31
52 Week Hoogtepunt	CA$0.38
52 Week Laag	CA$0.15
Bèta	1.52
11 maand verandering	26.53%
3 maanden verandering	3.33%
1 Jaar Verandering	82.35%
33 jaar verandering	-50.00%
5 jaar verandering	-21.52%
Verandering sinds IPO	138.46%

Recent nieuws en updates

Nova Leap Health Corp.'s (CVE:NLH) 35% Share Price Surge Not Quite Adding Up

Oct 31

Risks Still Elevated At These Prices As Nova Leap Health Corp. (CVE:NLH) Shares Dive 27%

Sep 12

Nova Leap Health Corp.'s (CVE:NLH) 33% Price Boost Is Out Of Tune With Revenues

Jun 08

Should Shareholders Reconsider Nova Leap Health Corp.'s (CVE:NLH) CEO Compensation Package?

May 31

Recent updates

Nova Leap Health Corp.'s (CVE:NLH) 35% Share Price Surge Not Quite Adding Up

Oct 31

Risks Still Elevated At These Prices As Nova Leap Health Corp. (CVE:NLH) Shares Dive 27%

Sep 12

Nova Leap Health Corp.'s (CVE:NLH) 33% Price Boost Is Out Of Tune With Revenues

Jun 08

Should Shareholders Reconsider Nova Leap Health Corp.'s (CVE:NLH) CEO Compensation Package?

May 31

Rendement voor aandeelhouders

	NLH	CA Healthcare	CA Markt
7D	0%	0.1%	-1.5%
1Y	82.4%	35.5%	21.1%

Rendement versus industrie: NLH exceeded the Canadian Healthcare industry which returned 35.5% over the past year.

Rendement versus markt: NLH exceeded the Canadian Market which returned 21.1% over the past year.

Prijsvolatiliteit

Is NLH's price volatile compared to industry and market?
NLH volatility
NLH Average Weekly Movement	11.8%
Healthcare Industry Average Movement	4.1%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	17.5%
10% least volatile stocks in CA Market	2.9%

Stabiele aandelenkoers: NLH has not had significant price volatility in the past 3 months compared to the Canadian market.

Volatiliteit in de loop van de tijd: NLH's weekly volatility (12%) has been stable over the past year.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2015	n/a	Chris Dobbin	novaleaphealth.com

Nova Leap Health Corp. biedt, samen met haar dochterondernemingen, thuiszorg en gezondheidszorg aan in de Verenigde Staten en Canada. De diensten omvatten dementiezorg, gezelschap, persoonlijke en geschoolde verpleging, respijtzorg, koken en maaltijdbereiding, baden, aankleden, verzorging, huishouding, boodschappen, vervoer en medicatieherinneringen. Het bedrijf werd opgericht in 2015 en heeft zijn hoofdkantoor in Halifax, Canada.

Nova Leap Health Corp. Samenvatting

Hoe verhouden de winst en inkomsten van Nova Leap Health zich tot de beurswaarde?
NLH fundamentele statistieken
Marktkapitalisatie	CA$26.76m
Inkomsten(TTM)	CA$175.53k
Inkomsten(TTM)	CA$36.11m

152.4x

Koers/Winstverhouding

0.7x

P/S-verhouding

Is NLH overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
NLH resultatenrekening (TTM)
Inkomsten	US$25.87m
Kosten van inkomsten	US$15.94m
Brutowinst	US$9.94m
Overige uitgaven	US$9.81m
Inkomsten	US$125.77k

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	0.0015
Brutomarge	38.40%
Nettowinstmarge	0.49%
Schuld/Eigen Vermogen Verhouding	0.9%

Hoe presteerde NLH op de lange termijn?

Bekijk historische prestaties en vergelijking

NLH Overzicht aandelen

Beloningen

Risicoanalyse

Nova Leap Health Corp. Concurrenten

TSXV:NPTH

CA$9.0m

TSXV:ARC

CA$8.8m

TSXV:PHA

CA$8.0m

TSXV:JUMP

CA$4.8m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Nova Leap Health Corp.'s (CVE:NLH) 35% Share Price Surge Not Quite Adding Up

Risks Still Elevated At These Prices As Nova Leap Health Corp. (CVE:NLH) Shares Dive 27%

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: US$0.003 (vs US$0.002 loss in 2Q 2023)

Nova Leap Health Corp.'s (CVE:NLH) 33% Price Boost Is Out Of Tune With Revenues

Should Shareholders Reconsider Nova Leap Health Corp.'s (CVE:NLH) CEO Compensation Package?

Recent updates

Nova Leap Health Corp.'s (CVE:NLH) 35% Share Price Surge Not Quite Adding Up

Risks Still Elevated At These Prices As Nova Leap Health Corp. (CVE:NLH) Shares Dive 27%

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: US$0.003 (vs US$0.002 loss in 2Q 2023)

Nova Leap Health Corp.'s (CVE:NLH) 33% Price Boost Is Out Of Tune With Revenues

Should Shareholders Reconsider Nova Leap Health Corp.'s (CVE:NLH) CEO Compensation Package?

First quarter 2024 earnings released: EPS: US$0.005 (vs US$0.003 loss in 1Q 2023)

Insufficient new directors

Nova Leap Health Corp., Annual General Meeting, Jun 07, 2024

Nova Leap Health Corp. (CVE:NLH) Looks Just Right With A 28% Price Jump

Full year 2023 earnings released

Market Participants Recognise Nova Leap Health Corp.'s (CVE:NLH) Revenues

Second quarter 2023 earnings released: US$0.002 loss per share (vs US$0 in 2Q 2022)

Nova Leap Health Corp. Announces Impairment for the Second Quarter Ended June 30, 2023

Nova Leap Health Corp. to Report Q2, 2023 Results on Aug 10, 2023

Nova Leap Health Corp. Announces Change of Corporate Secretary

Nova Leap Health Corp. (CVE:NLH) Investors Are Less Pessimistic Than Expected

New minor risk - Share price stability

Independent Director recently bought CA$99k worth of stock

First quarter 2023 earnings released: US$0.003 loss per share (vs US$0.005 loss in 1Q 2022)

Full year 2022 earnings released: US$0.01 loss per share (vs US$0.024 profit in FY 2021)

Does Nova Leap Health (CVE:NLH) Have A Healthy Balance Sheet?

Third quarter 2022 earnings released: EPS: US$0.007 (vs US$0.016 in 3Q 2021)

Third quarter 2022 earnings released: EPS: US$0.007 (vs US$0.016 in 3Q 2021)

Now 22% undervalued after recent price drop

Now 27% undervalued after recent price drop

Nova Leap Health Corp. announced that it has received CAD 2.385056 million in funding

Nova Leap Health Corp. announced that it expects to receive CAD 2.5 million in funding

Independent Director recently bought CA$94k worth of stock

Now 23% undervalued after recent price drop

Calculating The Intrinsic Value Of Nova Leap Health Corp. (CVE:NLH)

Second quarter 2022 earnings released: EPS: US$0 (vs US$0.005 in 2Q 2021)

Nova Leap Health (CVE:NLH) Is Carrying A Fair Bit Of Debt

First quarter 2022 earnings released: US$0.005 loss per share (vs US$0.013 profit in 1Q 2021)

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Nova Leap Health Corp., Annual General Meeting, Apr 21, 2022

Independent Director recently bought CA$99k worth of stock

Nova Leap Health Corp. (TSXV:NLH) completed the acquisition of Home Care Business With Operations Located in Kentucky and Indiana.

Independent Chairman of the Board recently bought CA$53k worth of stock

Third quarter 2021 earnings released: EPS US$0.02 (vs US$0.007 in 3Q 2020)

Estimating The Intrinsic Value Of Nova Leap Health Corp. (CVE:NLH)

Nova Leap Health Corp. (TSXV:NLH) acquired Business assets of a home care services company located in Oklahoma.

Second quarter 2021 earnings released: EPS US$0.01 (vs US$0.012 loss in 2Q 2020)

Independent Director exercised options to buy CA$228k worth of stock.

Nova Leap Health Corp entered into an agreement to acquire Home care services company.

Nova Leap Health Corp. announced that it has received CAD 5.499999 million in funding

Nova Leap Health Corp. announced that it expects to receive CAD 1.999999 million in funding

First quarter 2021 earnings released: EPS US$0.01 (vs US$0.005 in 1Q 2020)

Nova Leap Health Corp. Appoints Marie Mullally to Board of Directors

Nova Leap Health (CVE:NLH) Strong Profits May Be Masking Some Underlying Issues

Full year 2020 earnings released: EPS US$0.02 (vs US$0.017 loss in FY 2019)

Revenue misses expectations

Nova Leap Health Corp., Annual General Meeting, Apr 29, 2021

New 90-day high: CA$0.87

New 90-day high: CA$0.58

Third quarter 2020 earnings released: EPS US$0.01

New 90-day high: CA$0.48

New 90-day high: CA$0.40

New 90-day high - CA$0.38